Department of Anesthesia, Renmin Hospital of Wuhan University, Wuhan Hubei, China.
Mediators Inflamm. 2020 May 6;2020:2094948. doi: 10.1155/2020/2094948. eCollection 2020.
Neuropathic pain is an intractable comorbidity of spinal cord injury. Increasing noncoding RNAs have been implicated in neuropathic pain development. lncRNAs have been recognized as significant regulators of neuropathic pain. lncRNA Small Nucleolar RNA Host Gene 4 (SNHG4) is associated with several tumors. However, the molecular mechanisms of SNHG4 in neuropathic pain remain barely documented. Here, we evaluated the function of SNHG4 in spinal nerve ligation (SNL) rat models. We observed that SNHG4 was significantly upregulated in SNL rat. Knockdown of SNHG4 was able to attenuate neuropathic pain progression via regulating behaviors of neuropathic pain including mechanical and thermal hyperalgesia. Moreover, knockdown of SNHG4 could repress the neuroinflammation via inhibiting IL-6, IL-12, and TNF- while inducing IL-10 levels. Additionally, miR-423-5p was predicted as the target of SNHG4 by employing bioinformatics analysis. miR-423-5p has been reported to exert significantly poorer in several diseases. However, the role of miR-423-5p in the development of neuropathic pain is needed to be clarified. Here, in our investigation, RIP assay confirmed the correlation between miR-423-5p and SNHG4. Meanwhile, we found that miR-423-5p was significantly decreased in SNL rat models. SNHG4 regulated miR-423-5p expression negatively. As exhibited, the loss of miR-423-5p contributed to neuropathic pain progression, which was rescued by the silence of SNHG4. Therefore, our study indicated SNHG4 as a novel therapeutic target for neuropathic pain via sponging miR-423-5p.
神经性疼痛是脊髓损伤的一种难治性合并症。越来越多的非编码 RNA 被认为与神经性疼痛的发展有关。lncRNA 已被认为是神经性疼痛的重要调节因子。长链非编码 RNA 小核仁 RNA 宿主基因 4(SNHG4)与几种肿瘤有关。然而,SNHG4 在神经性疼痛中的分子机制仍鲜有报道。在这里,我们评估了 SNHG4 在脊神经结扎(SNL)大鼠模型中的功能。我们观察到 SNHG4 在 SNL 大鼠中显著上调。SNHG4 的敲低能够通过调节神经性疼痛的行为,包括机械性和热痛觉过敏,来减轻神经性疼痛的进展。此外,SNHG4 的敲低能够通过抑制白细胞介素 6(IL-6)、白细胞介素 12(IL-12)和肿瘤坏死因子-α(TNF-α)而诱导白细胞介素 10(IL-10)水平来抑制神经炎症。此外,通过生物信息学分析预测 SNHG4 的靶标是 miR-423-5p。miR-423-5p 已被报道在几种疾病中发挥显著的不良作用。然而,miR-423-5p 在神经性疼痛发展中的作用仍有待阐明。在这里,在我们的研究中,RIP 实验证实了 miR-423-5p 和 SNHG4 之间的相关性。同时,我们发现 miR-423-5p 在 SNL 大鼠模型中显著下调。SNHG4 负调控 miR-423-5p 的表达。结果表明,miR-423-5p 的缺失促进了神经性疼痛的进展,而 SNHG4 的沉默则挽救了这一进程。因此,我们的研究表明,SNHG4 通过海绵吸附 miR-423-5p 成为神经性疼痛的一个新的治疗靶点。